Most Read Articles
03 Mar 2016
The Drug Control Authority (DCA) of Malaysia has approved a new indication for the long-acting somatostatin analogue lanreotide. This new indication is for the treatment of grade 1 and low grade 2 gastroenteropancreatic neuroendocrine tumours (GEP-NETs)—of midgut, pancreatic or unknown origin except the hindgut—in adult patients with unresectable locally advanced or metastatic disease.

Patients with genital warts at high risk of cancer

25 Aug 2017
Teen girls, due to insecurity, are turning to labiaplasty to measure up to physical perfection.

Patients with genital warts have higher risk of cancers related to human papillomavirus (HPV) infection, particularly anogenital malignancies, a new study has shown.

During the study period, 21,763 patients (59.67 percent female) developed genital warts, with the incidence being highest in the 20 to 29 age group. During follow-up, 1,002 (4.60 percent) cancer cases were recorded with a mean time to cancer diagnosis of 4.17±3.06 years.

Of the 1,002 cancer patients, 69.96 percent (n=701) were female while 30.04 percent (n=301) were male (standardized incidence ratio [SIR] compared to general population, 1.95; 95 percent CI, 1.83 to 2.07).

Excess risk was marginally higher in males (SIR, 1.87; 1.66 to 2.08) than in females (SIR, 1.80; 1.66 to 1.93) because of anogenital cancers in the anus and penis (SIR, 5.87; 2.04 to 9.71) and HPV-related cancers (SIR, 13.57; 3.52 to 23.62). Females had higher risk of anogenital cancers in the cervix in situ (SIR, 3.34; 2.20 to 4.48).

The risk of smoking-related malignancies, such as cancers of the pharynx, oesophagus, larynx, liver and pancreas, among others, were markedly higher in males (SIR, 1.83; 1.47 to 2.19) and females (SIR, 1.88; 1.40 to 2.36) compared to the general population.

Specifically, risk of lung cancer in males (SIR, 2.0; 1.4 to 2.8) and kidney cancer in females (SIR, .41; 1.19 to 3.63) were higher than in the general population.

Data used in the study were retrieved from the National Health Insurance Research Database of Taiwan. Only those diagnosed with genital warts were included. Patients who had previous cancer diagnoses or were diagnosed within 30 days of the genital warts were excluded.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
03 Mar 2016
The Drug Control Authority (DCA) of Malaysia has approved a new indication for the long-acting somatostatin analogue lanreotide. This new indication is for the treatment of grade 1 and low grade 2 gastroenteropancreatic neuroendocrine tumours (GEP-NETs)—of midgut, pancreatic or unknown origin except the hindgut—in adult patients with unresectable locally advanced or metastatic disease.